LTAS
REGN icon

Linden Thomas Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Linden Thomas Advisory Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Sell
5,106
-16
-0.3% -$10.9K 0.26% 111
2026
Q1 		$3.96M Buy
5,122
+662
+15% +$507K 0.38% 65
2025
Q4 		$3.44M Buy
4,460
+47
+1% +$31.9K 0.35% 75
2025
Q3 		$2.48M Buy
4,413
+178
+4% +$101K 0.25% 115
2025
Q2 		$2.22M Buy
4,235
+1,045
+33% +$583K 0.24% 123
2025
Q1 		$2.02M Buy
3,190
+135
+4% +$92.9K 0.26% 126
2024
Q4 		$2.18M Buy
3,055
+241
+9% +$202K 0.28% 116
2024
Q3 		$2.96M Buy
2,814
+245
+10% +$273K 0.4% 54
2024
Q2 		$2.7M Sell
2,569
-211
-8% -$205K 0.42% 51
2024
Q1 		$2.68M Buy
2,780
+173
+7% +$165K 0.43% 41
2023
Q4 		$2.29M Buy
2,607
+136
+6% +$112K 0.43% 47
2023
Q3 		$2.03M Sell
2,471
-626
-20% -$492K 0.45% 39
2023
Q2 		$2.23M Buy
3,097
+61
+2% +$47K 0.49% 33
2023
Q1 		$2.49M Buy
3,036
+106
+4% +$79.9K 0.62% 25
2022
Q4 		$2.11M Buy
+2,930
New +$2.16M 0.6% 25

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Linden Thomas Advisory Services's REGN Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Regeneron Pharmaceuticals (REGN) stake by 0.31% in Q2 2026, selling an estimated $10.9K and leaving 5,106 shares worth $3.18M. The position accounts for 0.26% of the portfolio, ranked #111.

Linden Thomas Advisory Services first reported a position in REGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.96M in Q1 2026. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Linden Thomas Advisory Services held 5,106 shares of Regeneron Pharmaceuticals worth $3.18M as of Q2 2026.
  • Linden Thomas Advisory Services sold 16 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.9K.
  • Regeneron Pharmaceuticals made up 0.26% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #111 holding.
  • Linden Thomas Advisory Services first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Linden Thomas Advisory Services's Regeneron Pharmaceuticals position peaked at $3.96M in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.